Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

The Nuffield Department of Medicine (NDM) at the University of Oxford has a global reach and significant breadth in terms of capabilities and capacity.

Behind the Title - Becoming an Oxford Professor (at NDM): Featuring Professor Sassy Molyneux

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford. In our second feature, we hear from Sassy Molyneux, Professor in Global Health, spanning health policy and systems research, and empirical ethics. Sassy is an interdisciplinary researcher, with a background in human geography, behavioural research and organisational studies.

Inaugural Sir John Bell Lecture Celebrates a Legacy of Innovation and the Future of Human Health

Creating a map of every cell in the human body is one of the most ambitious goals in modern science. Through the Human Cell Atlas, an international collaboration involving thousands of researchers worldwide, scientists are building a reference map of human cells that is reshaping understanding of health and disease.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit

The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.

Inaugural Sir John Bell Lecture Celebrates a Legacy of Innovation and the Future of Human Health

Creating a map of every cell in the human body is one of the most ambitious goals in modern science. Through the Human Cell Atlas, an international collaboration involving thousands of researchers worldwide, scientists are building a reference map of human cells that is reshaping understanding of health and disease.

Patient enrolment begins in PARTNERS trial to identify the first effective treatments for Bundibugyo virus disease

Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from Médecins Sans Frontières (MSF). International trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.

Professor Le Van Tan appointed Interim Director of OUCRU Ho Chi Minh City

We are pleased to announce that Professor Lê Văn Tấn has been appointed Interim Director of OUCRU Ho Chi Minh City, with effect from 24 June.

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body’s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.

Oxford University apprentices celebrated at Oxfordshire Apprenticeship Awards 2026

Two apprentices from Oxford were recognised at the Oxfordshire Apprenticeship Awards 2026, highlighting the success and impact of apprenticeship opportunities across the Department and the wider University of Oxford.

Academy of Medical Sciences elects three researchers from the Nuffield Department of Medicine as new Fellows

The Academy of Medical Sciences has elected four University of Oxford biomedical and health scientists to its fellowship in 2026, with three of the researchers based within the Nuffield Department of Medicine.

New study improves early detection of life threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.

New rabies vaccine could provide protection for adults and children with a single dose

A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

An Oxford University spinout rooted in Nuffield Department of Medicine and Radcliffe Department of Medicine research was recently acquired by global biotechnology company Amgen in a deal worth up to $840 million. The acquisition highlights how the strength of Oxford’s collaborative, translational research environment, rooted in world leading science, is accelerating the development of potential new targeted treatments for cancers.

Professor Trey Ideker appointed Director of the Big Data Institute

Professor Trey Ideker has been appointed as the new Director of the University of Oxford's Big Data Institute (BDI). He will take up the role by June and continue to advance the institute's mission to drive transformative research into the causes, consequences, prevention and treatment of disease.

International Women’s Day: Women Advancing Science and Global Health

Women are central to scientific discovery and academic leadership worldwide, contributing as researchers, clinicians, educators and technical specialists across the global research community. Their work advances knowledge and strengthens health systems to ensure that science reflects the diverse societies it aims to serve.

Behind the Title: Becoming an Oxford Professor (at NDM), featuring Professor Phaik Yeong Cheah

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford. In our first feature, we hear from Professor Phaik Yeong Cheah, Head of Bioethics and Engagement at the Mahidol Oxford Tropical Medicine Research Unit (MORU), Nuffield Department of Medicine, based in Bangkok.

Oxford joins new West Africa consortium to accelerate climate and health solutions

Researchers from the University of Oxford have joined African universities and regional experts who are working with Wellcome to establish new science and policy consortiums that will address the escalating public health crisis driven by climate change - saving lives and livelihoods.

New Oxford-led trial explores if the immune system can be trained to control HIV

Can the immune system be trained to control HIV without continuous medication? A new Oxford-led clinical trial is exploring whether immune-based strategies could support longer-term viral control after stopping antiretroviral therapy.

Load More